The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients (COLLECT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
InDex Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01493960
First received: December 12, 2011
Last updated: June 16, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)